Phase II study of Sotorasib plus carboplatin-pemetrexed in advanced or recurrent chemotherapy naive non-squamous, non-small cell lung cancer patients harboring KRAS G12C mutation : SCARLET study (WJOG14821L)

Authors
Category Primary study
Registry of TrialsJapan Primary Registry Network
Year 2021
This article has no abstract
Epistemonikos ID: d73b8ba1cc78ac7f54cc85cee0db9cf97bc4a232
First added on: Apr 11, 2025